Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Cited In for PubMed (Select 15883263)

1.

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN.

BMC Neurol. 2015 Aug 20;15:146. doi: 10.1186/s12883-015-0403-4.

2.

[Formula: see text] Aging, Practice Effects, and Genetic Risk in the Wisconsin Registry for Alzheimer's Prevention.

Jonaitis EM, Koscik RL, La Rue A, Johnson SC, Hermann BP, Sager MA.

Clin Neuropsychol. 2015 May;29(4):426-41. doi: 10.1080/13854046.2015.1047407. Epub 2015 May 27.

3.

Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.

Zeifman LE, Eddy WF, Lopez OL, Kuller LH, Raji C, Thompson PM, Becker JT.

J Alzheimers Dis. 2015 Feb 26. [Epub ahead of print]

PMID:
25720412
4.

Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.

Albert M, Soldan A, Gottesman R, McKhann G, Sacktor N, Farrington L, Grega M, Turner R, Lu Y, Li S, Wang MC, Selnes O.

Curr Alzheimer Res. 2014;11(8):773-84.

5.

Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.

Bennett DA, Yu L, De Jager PL.

Biochem Pharmacol. 2014 Apr 15;88(4):617-30. doi: 10.1016/j.bcp.2014.01.037. Epub 2014 Feb 6. Review.

6.

Disease progression in patients with single, large-scale mitochondrial DNA deletions.

Grady JP, Campbell G, Ratnaike T, Blakely EL, Falkous G, Nesbitt V, Schaefer AM, McNally RJ, Gorman GS, Taylor RW, Turnbull DM, McFarland R.

Brain. 2014 Feb;137(Pt 2):323-34. doi: 10.1093/brain/awt321. Epub 2013 Nov 25.

7.

Memory consolidation in aging and MCI after 1 week.

Walsh CM, Wilkins S, Bettcher BM, Butler CR, Miller BL, Kramer JH.

Neuropsychology. 2014 Mar;28(2):273-80. doi: 10.1037/neu0000013. Epub 2013 Nov 11.

8.

The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Swerdlow RH, Burns JM, Khan SM.

Biochim Biophys Acta. 2014 Aug;1842(8):1219-31. doi: 10.1016/j.bbadis.2013.09.010. Epub 2013 Sep 23. Review.

9.

Relation of neuropathology with cognitive decline among older persons without dementia.

Boyle PA, Yu L, Wilson RS, Schneider JA, Bennett DA.

Front Aging Neurosci. 2013 Sep 9;5:50. doi: 10.3389/fnagi.2013.00050. eCollection 2013.

10.

Cognitive declines precede and predict functional declines in aging and Alzheimer's disease.

Zahodne LB, Manly JJ, MacKay-Brandt A, Stern Y.

PLoS One. 2013 Sep 2;8(9):e73645. doi: 10.1371/journal.pone.0073645. eCollection 2013.

11.

Epigenetic changes in the progression of Alzheimer's disease.

Bradley-Whitman MA, Lovell MA.

Mech Ageing Dev. 2013 Oct;134(10):486-95. doi: 10.1016/j.mad.2013.08.005. Epub 2013 Sep 3.

12.

Much of late life cognitive decline is not due to common neurodegenerative pathologies.

Boyle PA, Wilson RS, Yu L, Barr AM, Honer WG, Schneider JA, Bennett DA.

Ann Neurol. 2013 Sep;74(3):478-89. doi: 10.1002/ana.23964. Epub 2013 Jul 10.

13.

Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes.

Fung WL, Naylor MG, Bennett DA, Lange C, Blacker D.

Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):770-8. doi: 10.1002/ajmg.b.32151. Epub 2013 May 6.

14.

Neuropathological approaches to cerebral aging and neuroplasticity.

Jellinger KA, Attems J.

Dialogues Clin Neurosci. 2013 Mar;15(1):29-43. Review.

15.

CERAD practice effects and attrition bias in a dementia prevention trial.

Mathews M, Abner E, Caban-Holt A, Kryscio R, Schmitt F.

Int Psychogeriatr. 2013 Jul;25(7):1115-23. doi: 10.1017/S1041610213000367. Epub 2013 Apr 10.

16.

Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease.

Ertekin-Taner N, De Jager PL, Yu L, Bennett DA.

Curr Genet Med Rep. 2013 Mar;1(1):39-51. Epub 2013 Jan 22.

17.

The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.

Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ.

JAMA Neurol. 2013 Apr;70(4):488-95. doi: 10.1001/2013.jamaneurol.405.

18.

Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.

Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, Llebaria G, García-Sánchez C, Pascual-Sedano B, Delfino M, Kulisevsky J, Gómez-Ansón B.

PLoS One. 2013;8(1):e54980. doi: 10.1371/journal.pone.0054980. Epub 2013 Jan 24.

19.

Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial.

Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA; PREADViSE Investigators, Crowley JJ; SELECT Investigators.

Trials. 2012 Nov 20;13:217. doi: 10.1186/1745-6215-13-217.

20.

Relation of neuropathology to cognition in persons without cognitive impairment.

Bennett DA, Wilson RS, Boyle PA, Buchman AS, Schneider JA.

Ann Neurol. 2012 Oct;72(4):599-609. doi: 10.1002/ana.23654.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk